• 제목/요약/키워드: Malignant Tumor

검색결과 1,950건 처리시간 0.037초

Pancreatic metastasis from malignant phyllodes tumor of the breast

  • Lee, Seung Eun;Bae, Young Kyung;Choi, Joon Hyuk
    • Journal of Yeungnam Medical Science
    • /
    • 제38권1호
    • /
    • pp.78-82
    • /
    • 2021
  • Pancreatic metastasis from malignant phyllodes tumor (PT) of the breast is rare, and only a few cases have been reported in the literature. Here, we report a case of pancreatic metastasis from malignant PT of the breast in a 48-year-old woman. She had had three episodes of recurrence of malignant PT in her right breast. She presented with epigastric pain for 2 months. Computed tomography and magnetic resonance imaging revealed a 6 cm-sized, well-defined, heterogeneous mass with peripheral enhancement in the body of the pancreas. Endoscopic ultrasonography-guided fine-needle aspiration was performed, and the pathologic report suggested spindle cell mesenchymal neoplasm. Subsequently, surgical excision was performed, and the mass was confirmed as a metastatic malignant PT. The imaging findings are discussed and the literature is briefly reviewed in this report.

슬부에 발생한 낮은 악성도의 연부조직 거대 세포종 - 증례 보고 - (Soft Tissue Giant Cell Tumor of Low Malignant Potential - Case Report -)

  • 이은우;강기서;강수용;이한준;김종원;이기현;박영욱
    • 대한골관절종양학회지
    • /
    • 제9권1호
    • /
    • pp.101-104
    • /
    • 2003
  • Folope 등(1999년)은 악성 연부조직 거대 세포종과 임상적, 병리학적, 면역조직화학적으로 유사하나, 악성도가 낮은 연부조직 거대 세포종을 보고하였다. 본 교실에서 치료한 1례는 30세 여자 환자로 내원 1년전부터 우측 슬관절 전외측부에 만져지는 종물과 동통을 주소로 내원하였다. 절제 생검을 통한 조직학적 소견상 거대 세포와 함께 호산성 세포질과 소포성의 핵을 지닌 다형성의 기질 세포 병변은 낮은 악성도의 연부조직 거대 세포종에 합당하였고, 이에 저자들은 낮은 악성도의 연부조직 거대 세포종 1례를 경험하였기에 문헌고찰과 함께 보고하는 바이다.

  • PDF

복합화학요법에 반응한 악성 사구체 종양 1예 (A Case Report of Malignant Glomus Tumor Responding to Combination Chemotherapy)

  • 이상윤;최인실;박숙련;김도연;김광현;김노경;허대석
    • 대한두경부종양학회지
    • /
    • 제18권2호
    • /
    • pp.219-222
    • /
    • 2002
  • Malignant glomus tumor is a very rare disease originating from the paraganglia system through the body. Glomus tumor, also known as paraganglioma, usually are considered benign, and arises in a variety of head and neck locations, most of which include the carotid body, the vagus nerve, and the jugulotympanic area. The most widely accepted management of benign glomus tumor is surgical extiration. Here, we report a case of recurrent laryngeal glomus tumor which is proven malignant and metastatic to the brain and the lungs. We have treated the patient with combination chemotherapy and radiation to the brain, the result of which is partial response in terms of decreased size of metastatic lung lesions.

악성 골 종양으로 오인된 급속 파괴형 고관절증 - 증례 보고 - (Rapidly Destructive Coxarthrosis Mimicking a Malignant Bone Tumor - A Case Report -)

  • 이형석;김정렬
    • 대한골관절종양학회지
    • /
    • 제14권2호
    • /
    • pp.203-207
    • /
    • 2008
  • 급속 파괴형 고관절증(Rapidly destructive coxarthrosis)은 고관절에 발생하여 급속한 골파괴를 일으키며 현재까지 확실한 원인이 밝혀지지 않은 드문 질환이다. 임상적으로 극심한 고관절 통증과 파행을 나타내며, 방사선학적으로 수개월 내에 급속한 대퇴골두의 파괴를 일으키므로 류마토이드 관절염, 세균성 관절염, 신경병성 관절증 및 골종양과 감별을 요한다. 저자들은 우측 대퇴골두에 발생하여 4개월만에 급속한 골파괴성 병변을 보여 악성 골종양으로 오인되어 타 병원으로부터 전원 되었던 80세 여자 환자의 급속 파괴형 고관절증을 보인 증례를 경험하였기에 이를 문헌 고찰과 함께 보고하는 바이다.

  • PDF

두피에 재발한 악성증식모근초종양 1례 (A Case of Recurred Malignant Proliferating Trichilemmal Tumor of the Scalp)

  • 이세빈;이원재;탁관철;김세훈
    • Archives of Plastic Surgery
    • /
    • 제33권4호
    • /
    • pp.491-494
    • /
    • 2006
  • Purpose: To report the case of recurred malignant proliferating trichilemmal tumor on scalp Methods: Case report and literature review Results: A 40-year-old man presented with a recurred malignant proliferating trichilemmal tumor, which developed on the occipital area. It was $8{\times}9{\times}4.5cm$ in size, protruded, firm and non-tender mass. This tumor was widely excised including normal skin margin and pericranium. Immediate reconstruction using free latissimus dorsi muscle flap and skin graft were done. Histopathologic examination revealed abrubt, compact trichilemmal keratinization in the central area of lobular epithelial proliferation. Conclusion: There has been no recurrence of tumor during follow-up period of nine months without adjuvant chemotherapy or radiotherapy.

Proteomic Analysis of Serum of Women with Elevated Ca-125 to Differentiate Malignant from Benign Ovarian Tumors

  • Li, Li;Xu, Yi;Yu, Chun-Xia
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제13권7호
    • /
    • pp.3265-3270
    • /
    • 2012
  • Clinically, elevated cancer antigen 125 (CA-125) in blood predicts tumor burden in a woman's body, especially in the ovary, but cannot differentiate between malignant or benign. We here used intensive modern proteomic approaches to identify predictive proteins in the serum of women with elevated CA-125 to differentiate malignant from benign ovarian tumors. We identified differentially expressed proteins in serum samples of ovarian cancer (OC) patients, benign ovarian tumor (BT) patients, and healthy control women using mass spectrometry-based quantitative proteomics. Both the OC and BT patients had elevated CA-125. Quantitation was achieved using isobaric tags for relative and absolute quantitation. We obtained 124 quantified differential serum proteins in OC compared with BT. Two proteins, apolipoprotein A-4 (APOA4) and natural resistance-associated macrophage 1, were verified using Western blotting. Proteome profiling applied to OC cases identified several differential serum proteins in the serum of women with elevated CA-125. A novel protein, APOA4, has the potential to be a marker for malignant tumor differentiation in the serum of women with elevated CA-125.

악성 흑색종에 대한 14년간의 임상적 고찰 (Clinical Study of Malignant Melanoma for recent 14 years)

  • 박동하;서승조;박명철;배남석;이일재
    • Archives of Plastic Surgery
    • /
    • 제36권3호
    • /
    • pp.299-305
    • /
    • 2009
  • Purpose: Recently, the incidence of malignant melanoma has been steadily increasing. Malignant melanoma is already known to have poorer prognosis than other primary skin cancers. Despite the poor prognosis, it is relatively less known to the public so that a number of patients visit hospital carrying advanced stage tumor. Yet, extensive study about malignant melanoma is currently insufficient, and specific guidelines and statistical figures in Korea are almost inexistent. Therefore, authors reviewed patients with malignant melanoma who have visited our hospital for last 14 years. Methods: Between January 1994 and January 2008, 62 patients were diagnosed with malignant melanoma at our hospital. A retrospective study was performed with data from patients' charts and biopsy results. Annual incidence, mean age of onset, gender, tumor location, tumor thickness, pathologic ulceration, clinicopathologic subtype, and clinical AJCC stage were evaluated. Analysis of factors associated with survival were performed using the Cox proportional hazard model. Kaplan - Meier method was used to generate survival curves. Results: Clinicopathologic features of 62 patients (32 male, 30 female) with average age of 57 years were evaluated. Most lesions were found in lower limb, and the most common subtype was acral lentiginous melanoma. We could also find that age, tumor thickness, and clinical stage were the only significant prognostic factors. Conclusion: Clinicopathologic features of malignant melanoma were analyzed in this study, but the result is not ready to be generalized because the number of cases is too small. Further study must be performed to report clinical guidelines for prognosis and treatment for malignant melanoma patients in Korea.

Prognostic Analysis of Primary Pulmonary Malignant Mesenchymal Tumors Treated Surgically

  • Sayan, Muhammet;Kankoc, Aykut;Ozkan, Dilvin;Celik, Ali;Kurul, Ismail Cuneyt;Tastepe, Abdullah Irfan
    • Journal of Chest Surgery
    • /
    • 제54권5호
    • /
    • pp.356-360
    • /
    • 2021
  • Background: Primary pulmonary malignant mesenchymal tumors are rare, constituting only 0.4% of all lung cancers. Since sarcomas are chemo/radio-resistant, surgical resection is the optimal treatment choice for patients with suitable medical conditions and tumor stage. In the present study, we analyzed the surgical outcomes and survival of primary pulmonary malignant mesenchymal tumors treated surgically. Methods: We retrospectively examined the records of patients with primary pulmonary malignant mesenchymal tumors who underwent surgical resection at our department between January 2010 and December 2020. Patient data were analyzed according to age, sex, tumor grade and stage, resection completeness, surgical type, and tumor histopathology. Results: Twenty patients were included in the study. There were 13 men (65%) and 7 women (35%). The median survival rate was 36 months (range, 19-53 months), and the 5-year overall survival rate was 37%. Unfavorable prognostic factors for overall survival included parietal pleural invasion (p=0.02), high tumor grade (p=0.02), advanced tumor stage (p=0.02), and extensive parenchymal resection (pneumonectomy and bilobectomy, p=0.01). The median length of disease-free survival was 31 months (interquartile range, 21-41 months), and the 5-year disease-free survival rate was 32%. The most unfavorable prognostic factors for recurrence were parietal pleural invasion (p=0.02), high tumor grade (p=0.01), and tumors requiring lung resection with chest wall resection (p=0.02). Conclusion: Primary malignant mesenchymal lung tumors are aggressive and have a high mortality rate. However, acceptable overall and disease-free survival rates can be obtained with surgical therapy.

이하선에 발생한 악성 타액선 호산성 과립세포종 1례 (A Case of Malignant Oncocytoma of the Parotid Gland)

  • 박용진;서영표;김민식;조승호;서병도
    • 대한두경부종양학회지
    • /
    • 제7권2호
    • /
    • pp.114-119
    • /
    • 1991
  • Malignant oncocytoma(oxyphil cell adenoma) is a extremely rare malignant tumor of the salivary glands and almost occurs in the parotid gland. A case of malignant oncocytoma of the parotid gland occurring in a 63 year old man is reported. Establishing a diagnosis of malignant oncocytoma essentially requires the application of two sets of criteria to the tumor under examination. First, the tumor cells must be identified as oncocyte and second, malignancy must be determined. Histochemical stains are not as useful as generally believed. Electron microscopy confirms the diagnosis by demonstrating an abundance of mitochondria. The diagnosis of malignant oncocytoma depends on several additional criteria in addition to cellular and nuclear pleomorphism, including lack of encapsulation, local infiltration, perineural and intravascular growth, and regional and/or distant metastasis. Satisfactory results from surgical resection and postoperative radiotherapy in our patient serve as additional experience in the treatment of this rare malignancy.

  • PDF

악성 근상피종의 세침흡인 세포학적 소견 -1 예 보고- (Fine Needle Aspiration Cytology of Malignant Myoepithelioma of the Salivary Gland - A Case Report -)

  • 이재화;박진경;허방
    • 대한세포병리학회지
    • /
    • 제13권1호
    • /
    • pp.28-32
    • /
    • 2002
  • Malignant myoepithelioma (myoepithelial carcinoma), is a very rare malignant epithelial accounting for less than 1% of all salivary gland tumors and has an intermediate malignant potential. We report a case of malignant myoepithelioma arising in the left parotid giand in a 54-year-old man, which was difficult to differentiate from pleomorphic adenoma and other malignant salivary gland neoplasms. Fine needle aspiration cytology of the parotid gland showed cellular smear, composed of overlapped sheets and clusters or individually scattered tumor cells without any acinic or ductal structures. The tumor cells were rather uniform, with distinct cell borders and moderate amount of cytoplasm. The eccentrically located nuclei were oval to round and pleomorphic and showed prominent nucleoli. A few clear cells were noted in the cellular aggregates Metachromatic matrix was seen between individual tumor cells in a lacelike fashion, resembling pleomorphic adenoma. According to the immunohistochemical staining, we recognized that the component cells are myoeplthelial in nature, showing reactivity for the S-100 protein, vimentin, and actin.